Champions Oncology (CSBR) is scheduled to report Q1 earnings on September 14, 2026.
In the most recent quarter (Q4), Champions Oncology reported EPS of $0.01, beating estimates of $-0.05 by 1.2%. Revenue came in at $13.84M, exceeding the estimate of $12.89M by 0.07%.
Over the last 4 quarters, Champions Oncology has averaged an EPS surprise of 2.44% and a revenue surprise of 0.05%.
Earnings Date
Jul 27
EPS
$0.010
Quarterly Revenue
$13.84M
Annual Revenue
$59.42M
as of Apr 30
Analyze the earnings history of Champions Oncology using advanced sorting and filters.
The chart below shows Champions Oncology's reported EPS compared to analyst estimates over recent quarters.
The chart below shows Champions Oncology's reported revenue compared to analyst estimates over recent quarters.
Champions Oncology (CSBR) is scheduled to report earnings on September 14, 2026. The last reported earnings were for reported on July 27, 2026 for Q4.
The Actual EPS was $0.01, which beat the estimate of $-0.05.
The Actual Revenue was $13.84M, which beat the estimate of $12.89M.
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q4 | Jul 27, 2026 | $0.01 | $-0.05 | 120.0 % |
| Q3 | Mar 12, 2026 | $0.04 | $0.09 | -55.6 % |
| Q2 | Dec 15, 2025 | $0.06 | $0.01 | 500.0 % |
| Q1 | Sep 15, 2025 | $0.02 | $-0.01 | 300.0 % |
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q4 | Jul 27, 2026 | $13.84M | $12.89M | 7.36 % |
| Q3 | Mar 12, 2026 | $16.56M | $16.61M | -0.33 % |
| Q2 | Dec 15, 2025 | $15.04M | $14.04M | 7.07 % |
| Q1 | Sep 15, 2025 | $14.00M | $13.51M | 3.57 % |